Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.
Stefanie AeppliEric Innocents EbouletTim EisenBernard EscudierStefanie FischerJames LarkinViktor GruenwaldDavid McDermottJan OldenburgAurelius OmlinCamillio PortaBrian RiniManuela SchmidingerCora SternbergChristian RothermundtPublished in: ESMO open (2020)
mccRCC treatment modifications in light of the coronavirus pandemic are variable, with a shift from ICI/ICI to ICI/TKI or TKI monotherapy.